Israel Active

Scientists from Israel’s Weizmann Institute and Sheba Medical Center have compiled the first detailed map of the various activity areas in the human small intestine, revealing what makes it so effective at absorbing nutrients and protecting the body from infection.   

Latest article about Israel’s NanoSynex (see  previously) and its antibiotic diagnosis test. The $11 million funding from investors, the IAA and Europe has helped it develop the product to test up to 20 patients at once and determine the correct antibiotic to use against bacteriological infections.

The US is now recommending the innovative pain relief treatment for pancreatic cancer patients developed at Israel’s Sheba Medical Center (see previously). 125 international patients received radiation treatment to the celiac plexus nerve. 53% reported significant benefit.

Israeli scientists from Tel Aviv and Glasgow Universities have engineered the parasite Toxoplasma gondii to deliver protein-based medical treatments through the blood-brain barrier. Their example delivered the protein MeCP2, to remedy a deficiency associated with Rett syndrome.

Harvard University Business Professor Regina Herzlinger has donated 50 life-saving blood infuser devices to about 20 Israeli hospitals and trauma centers. They replace blood lost during hemorrhaging and are especially crucial in the treatment of those wounded in the current war.

Israel’s PayZen has developed a fintech platform that allows hospitals to receive payment in advance for medical treatment invoices, thereby enabling US patients to benefit from interest-free payment plans without additional costs for their medical care.

Israel’s Dr. Linda Rubinstein moved from NASA to Sheba Medical Center and from Outer Space research to Inner space research. Her work focuses on mitochondria (the cell’s powerhouse). Stopping it from aging could contribute to the eradication of brain diseases such as Alzheimer’s and Parkinson’s.

Israel’s BAIBYS uses Machine Vision (MV) and Artificial Intelligence (AI) to select the best quality sperm for IVF success. It autonomously selects and collects the sperm to microinject into the egg. It uses high magnification and morphology (shape, structure, size, etc.).

Recent trials of the Lioness device developed by Israel’s PregnanTech showed a high rate of full-term births among women at high risk of pre-term birth. A US trial next year is planned, to help the company obtain FDA approval.

The NeuroSpeed AI analysis software from Israel’s NeuroBrave uses the photoplethysmogram (PPG) sensor on the back of a smartwatch to measure he length of time between heartbeats. Heart rate variability (HRV) is a good indicator of overall mental health.